BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32842999)

  • 1. Biobanking for glomerular diseases: a study design and protocol for KOrea Renal biobank NEtwoRk System TOward NExt-generation analysis (KORNERSTONE).
    Kang E; Kim Y; Kim YC; Kim E; Lee N; Kim Y; Lee S; Han S; Choe M; Hwang JH; Lee S; Park JI; Park JT; Lim BJ; Lee JP; An JN; Ryu DR; Kim JH; Kang HG; Lee HS; Moon KC; Joo KW; Oh KH; Han SS; Lee H; Kim DK;
    BMC Nephrol; 2020 Aug; 21(1):367. PubMed ID: 32842999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biobank for the molecular classification of kidney disease: research translation and precision medicine in nephrology.
    Muruve DA; Mann MC; Chapman K; Wong JF; Ravani P; Page SA; Benediktsson H
    BMC Nephrol; 2017 Jul; 18(1):252. PubMed ID: 28747168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Biobank of Nephrological Diseases in the Netherlands cohort: the String of Pearls Initiative collaboration on chronic kidney disease in the university medical centers in the Netherlands.
    Navis GJ; Blankestijn PJ; Deegens J; De Fijter JW; Homan van der Heide JJ; Rabelink T; Krediet RT; Kwakernaak AJ; Laverman GD; Leunissen KM; van Paassen P; Vervloet MG; Wee PM; Wetzels JF; Zietse R; van Ittersum FJ;
    Nephrol Dial Transplant; 2014 Jun; 29(6):1145-50. PubMed ID: 24151018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Canadian Glomerulonephritis Registry (CGNR) and Translational Research Initiative: Rationale and Clinical Research Protocol.
    Hildebrand AM; Barua M; Barbour SJ; Tennankore KK; Cattran DC; Takano T; Lam P; De Serres SA; Samanta R; Hladunewich MA; Fairhead T; Poyah P; Bush DD; MacLaren B; Sparkes D; Boll P; Jauhal A; John R; Avila-Casado C; Reich HN
    Can J Kidney Health Dis; 2022; 9():20543581221089094. PubMed ID: 35450151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of clinical presentation, pathological spectra, treatment and outcomes of biopsy-proven acute postinfectious glomerulonephritis in adult indigenous people of the Northern Territory of Australia.
    Ramanathan G; Abeyaratne A; Sundaram M; Fernandes DK; Pawar B; Perry GJ; Sajiv C; Majoni SW
    Nephrology (Carlton); 2017 May; 22(5):403-411. PubMed ID: 27062647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Kidney Disease After Acute Kidney Injury Requiring Continuous Renal Replacement Therapy and Its Impact on Long-Term Outcomes: A Multicenter Retrospective Cohort Study in Korea.
    An JN; Hwang JH; Kim DK; Lee H; Ahn SY; Kim S; Park JT; Kang SW; Oh YK; Kim YS; Lim CS; Oh HJ; Lee JP
    Crit Care Med; 2017 Jan; 45(1):47-57. PubMed ID: 27565014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glomerulonephritis and vasculitis as causes of arterial hypertension].
    Eicken S; Gugger M; Marti HP
    Ther Umsch; 2012 May; 69(5):283-94. PubMed ID: 22547360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
    Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
    Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of glomerular diseases in Taiwan: preliminary report of National Renal Biopsy Registry-publication on behalf of Taiwan Society of Nephrology.
    Chiu HF; Chen HC; Lu KC; Shu KH;
    BMC Nephrol; 2018 Jan; 19(1):6. PubMed ID: 29320993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A programme to spread eGFR graph surveillance for the early identification, support and treatment of people with progressive chronic kidney disease (ASSIST-CKD): protocol for the stepped wedge implementation and evaluation of an intervention to reduce late presentation for renal replacement therapy.
    Gallagher H; Methven S; Casula A; Thomas N; Tomson CR; Caskey FJ; Rose T; Walters SJ; Kennedy D; Dawnay A; Cassidy M; Fluck R; Rayner HC; Nation M
    BMC Nephrol; 2017 Apr; 18(1):131. PubMed ID: 28399810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal biopsy-driven molecular target identification in glomerular disease.
    Lindenmeyer MT; Kretzler M
    Pflugers Arch; 2017 Aug; 469(7-8):1021-1028. PubMed ID: 28664406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent glomerular disease after kidney transplantation: an update of selected areas and the impact of protocol biopsy.
    Morozumi K; Takeda A; Otsuka Y; Horike K; Gotoh N; Watarai Y
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():6-10. PubMed ID: 24842814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CONSTANCES Cohort Biobank: An Open Tool for Research in Epidemiology and Prevention of Diseases.
    Henny J; Nadif R; Got SL; Lemonnier S; Ozguler A; Ruiz F; Beaumont K; Brault D; Sandt E; Goldberg M; Zins M
    Front Public Health; 2020; 8():605133. PubMed ID: 33363097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in glomerular diseases with crescents.
    Yeter HH; Gonul I; Demirel E; Korucu B; Derici U
    Rom J Intern Med; 2019 Sep; 57(3):254-261. PubMed ID: 31075086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of TransplantLines: a prospective cohort study and biobank of solid organ transplant recipients.
    Eisenga MF; Gomes-Neto AW; van Londen M; Ziengs AL; Douwes RM; Stam SP; Osté MCJ; Knobbe TJ; Hessels NR; Buunk AM; Annema C; Siebelink MJ; Racz E; Spikman JM; Bodewes FAJA; Pol RA; Berger SP; Drost G; Porte RJ; Leuvenink HGD; Damman K; Verschuuren EAM; de Meijer VE; Blokzijl H; Bakker SJL
    BMJ Open; 2018 Dec; 8(12):e024502. PubMed ID: 30598488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney biopsy results versus clinical parameters on mortality and ESRD progression in 2687 patients with glomerulonephritis.
    Haider DG; Masghati S; Goliasch G; Mouhieddine M; Wolzt M; Fuhrmann V; Hörl WH; Kaider A; Soleiman A
    Eur J Clin Invest; 2014 Jun; 44(6):578-86. PubMed ID: 24749685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I; Krzymański M
    Przegl Lek; 1996; 53(5):443-53. PubMed ID: 8754411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Histologically Proven Glomerulonephritis in Africa: A Systematic Review and Meta-Analysis.
    Okpechi IG; Ameh OI; Bello AK; Ronco P; Swanepoel CR; Kengne AP
    PLoS One; 2016; 11(3):e0152203. PubMed ID: 27011216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.